Pentoxifylline
Drug Details
- Generic Name
- Pentoxifylline
- Brand Names
- Pentoxifylline
- Application Number
- ANDA075028
- Sponsor
- NuCare Pharmaceuticals,Inc.
- NDC Codes
- 9
- Dosage Forms
- TABLET, EXTENDED RELEASE, POWDER
- Routes
- ORAL
- Active Ingredients
- PENTOXIFYLLINE
Indications and Usage
INDICATIONS AND USAGE Pentoxifylline Extended-Release Tablets are indicated for the treatment of patients with intermittent claudication on the basis of chronic occlusive arterial disease of the limbs. Pentoxifylline Extended-Release Tablets can improve function and symptoms but is not intended to replace more definitive therapy, such as surgical bypass, or removal of arterial obstructions when treating peripheral vascular disease.